- Pfizer press launch (NYSE:PFE): Q2 Non-GAAP EPS of $0.60 beats by $0.14.
- Income of $13.28B (+2.2% Y/Y) beats by $260M.
- Revenues Grew 3% Operationally 12 months-over-12 months Regardless of Anticipated Decline in COVID Revenues
- Excluding Contributions from Comirnaty and Paxlovid, Revenues Grew 14% Operationally
- Raises Full-12 months 2024 Income Steerage to a Vary of $59.5 to $62.5 Billion vs $60.58B consensus and Raises Adjusted Diluted EPS Steerage to a Vary of $2.45 to $2.65 vs $2.37 consensus
